Related Experiment Video

Updated: Jun 9, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Conducting chemoprevention clinical trials: challenges and solutions

Ellen Richmond1, Ann O'Mara

  • 1Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA. richmone@mail.nih.gov

Seminars in Oncology
|September 7, 2010
PubMed

Insights

Executing chemoprevention clinical trials presents unique challenges. Phase II trials focus on biomarker modulation in at-risk groups, while Phase III trials assess cancer prevention efficacy in larger, healthier populations.

Area of Science:

  • Oncology
  • Clinical Trials
  • Preventive Medicine

Background:

  • Chemoprevention trials involve unique complexities compared to standard clinical research.
  • Phase II trials assess biomarker modulation in smaller, at-risk cohorts (30-200 participants).
  • Phase III trials evaluate cancer prevention efficacy in large populations (thousands), often with lower risk.

Purpose of the Study:

  • To outline the distinct challenges encountered in chemoprevention clinical trial execution.
  • To highlight the differences in participant recruitment and trial scope between Phase II and Phase III chemoprevention studies.
  • To emphasize the specialized skills required for chemoprevention trial teams.

Main Methods:

  • Review of challenges in Phase II chemoprevention trials focusing on biomarker modulation.
  • Analysis of considerations for Phase III chemoprevention trials, including large cohort accrual and toxicity monitoring.
  • Examination of participant communication and long-term commitment requirements.

Main Results:

  • Phase II trials require strict eligibility criteria for at-risk participants.
  • Phase III trials necessitate managing large, generally healthy cohorts and long-term toxicity surveillance.
  • Effective communication of risks/benefits and participant commitment are critical for both phases.

Conclusions:

  • Chemoprevention research adds significant complexity to clinical trial management.
  • Successful execution requires teams with specialized knowledge beyond basic scientific understanding.
  • Careful planning for participant accrual, safety monitoring, and long-term engagement is essential.

More Related Videos

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis07:40

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...